In pregnancy need higher oxygen to trigger increased production of
erythropoietin. As a result, increased plasma volume and red blood cells (erythrocytes) increases. However, the increase in plasma volume occurs in a proportion greater than the increase in erythrocytes resulting in decreased concentration of hemoglobin (Hb) due to hemodilution. Plasma volume expansion began in the 6th week of pregnancy and reaches a maximum at the 24th week of pregnancy, but may continue to rise until the 37th week. At its zenith, the plasma volume approximately 40% higher in pregnant women than women who are not pregnant. Decrease in hematocrit, hemoglobin concentration, and erythrocyte count usually appear in week 7 to all 8 of pregnancy and continued to decline until week 16 to 22 when the point of balance is reached. A study shows the change in Hb concentration in accordance with increasing gestational age. In the first trimester, Hb concentration appears to have declined, except in women who have had low hemoglobin levels (<11.5 g / dl). The lowest concentration found in the third trimester there was a slight increase in Hb, except in women who already have high hemoglobin levels (> 14.6 g / dl) in the first inspection.
Picture 1. Hemoglobin concentration during pregnancy
The cause of anemia is the most common nutrient deficiency. Often multiple deficiency is accompanied with clinical manifestations of infection, malnutrition, or hereditary disorders such as hemoglobinopathies. However, the underlying causes of anemia include nutritional intake is insufficient, inadequate absorption, increasing the missing nutrients, excessive requirements, and lack of utilization of haemopoietic nutrients. Approximately 75% of anemia in pregnancy is caused by an iron deficiency that shows a picture of microcytic hypochromic erythrocytes in the peripheral blood smear. The second commonest cause is a megaloblastic anemia caused by a deficiency of folic acid and vitamin B12 deficiency. Other causes of anemia are rarely found among other hemoglobinopathies, inflammation, toxicity of chemicals, and malignancy.
Reference : Ilmu Kandungan.2009.Jakarta:PT.Bina Pustaka Sarwono Prawirohardjo.page 775